Prominent US genomics Robert L. Strausberg, who directs the
National Cancer Institute's (NCI) Cancer Genomics office, has been
named as vice president for research at The Institute for Genomic
Engineers in the US are one step closer to mass-producing
therapeutic proteins needed by today's pharmaceutical industry.
Researchers claim to have achieved a major milestone in their
efforts to effectively produce human therapeutics...
The biotechnology industry in the state of British Columbia in
Canada could double the number of companies, attract large
revenue-generating biotechnology firms and create more than 5,000
new jobs within five years, says a strategic...
Strasbourg, France-based Aventis has announced its intention to
sell off part of its remaining stake in Rhodia, its loss-making
former specialty chemicals subsidiary. The move reduces its stake
in Rhodia to 15.3 per cent from 25.2...
A prominent US law professor from Stanford University has called
for an international treaty on sharing scientific and technological
information, to be based on the arrangements already agreed for
free trade under the World Trade...
As consolidation continues to mark the pharmaceutical industry,
more evidence to suggest that companies will increasingly turn to
biotechnology companies in order to gain the competitive edge comes
from a new study from Cutting Edge...
Edinburgh, Scotland will host the upcoming International Mass
Spectrometry Conference (IMSC) on 31 August to 5 September this
year. The conference organisers, the International Mass
Spectrometry Society asserts that the 'forward...
Billion dollar science and technology company Dowpharma, a business
unit of The Dow Chemical company, has announced new capabilities in
catalytic asymmetric hydroformylation (AHF) of olefins for
applications in the development and...
Akzo Nobel business unit Diosynth, which specialises in the
production of complex active biopharmaceutical ingredients for the
pharmaceutical sector, has developed a new method for manufacturing
synthetic peptides that, it claims,...
US company PPD is taking a stake in Chemokine Therapeutics, a
Canadian- and US-based biotechnology company, to continue
development of a proprietary peptide derived from a particular
chemokine that may make the peptide useful as a...
Canadian drug discovery company Phytobiotech has entered into an
agreement to supply Achillion Pharmaceuticals with purified, plant
derived small molecules (phytochemicals) from its PurePhytoLib
library. The collaboration marks a...
TUBITAK, the scientific and technical research council of Turkey,
with the support of the European Commission, is organising a Sixth
Framework Programme (FP6) information day and launch conference, to
take place from 24 to 25 April...